About Us

Our Journey

Established in 2016, Abryl Laboratories is a pharmaceutical enterprise specialising in the development and manufacturing of high-quality sterile injectable formulations. Our diversified product portfolio includes liquid injectables presented in ampoules, vials, and pre-filled syringes; lyophilised (freeze-dried) products in vials; as well as nano-milled formulations.
The foundation of the project was laid in 2016, with construction commencing in 2017. Remarkably, within just two years, by May 2019, our state-of-the-art manufacturing facility was fully commissioned and operational. Strategically located on a 22,342-square-meter green campus, the site features a purpose-built sterile manufacturing block designed to meet global regulatory expectations. This is complemented by a dedicated Research and Development (R&D) centre focused on formulation development, process optimisation, and comprehensive product lifecycle support. Our facility is equipped with advanced, automated technologies to enable seamless, high-precision manufacturing with minimal human intervention. Designed in full compliance with the latest U.S. FDA regulations and applicable international guidance, the site includes appropriately sized and classified areas to ensure efficient, streamlined, and fully compliant operations.
The successful implementation of digital technologies such as Document Management Systems (DMS), digital training platforms, electronic logbooks (eLogs), and Building Management Systems (BMS) has significantly enhanced operational efficiency, regulatory compliance, and data integrity within our pharmaceutical operations. These systems have streamlined critical processes—from document control and employee training to equipment monitoring and real-time data logging—while reducing manual errors and improving traceability. With these digital tools in place, we ensure compliance with global regulatory standards such as FDA 21 CFR Part 11 and EU Annex 11. The transition involved thorough workflow assessments, robust system validations, and comprehensive user training to ensure seamless adoption. This digital foundation not only strengthens our audit readiness and data-driven decision-making but also positions us for scalable growth and continuous improvement in a highly regulated and competitive industry.

Our Business

Abryl Laboratories operates as a trusted partner in Contract Development and Manufacturing (CDMO) and Contract Operations and Manufacturing (COM), offering comprehensive, end-to-end solutions to pharmaceutical companies worldwide. Our services encompass formulation development, technology transfer, scale-up, and commercial manufacturing of sterile injectable products. With advanced infrastructure, regulatory expertise, and a dedicated R&D team, we support clients at every stage of the product lifecycle—from early development through to market supply.
Technology Transfer

We collaborate with global partners to seamlessly transfer technology for the production of high-quality pharmaceutical products, ensuring scalability and regulatory compliance.

Product Development

Our dedicated R&D team focuses on the formulation and development of sterile injectables, leveraging innovative techniques and robust quality control systems.

Licensing

We offer flexible licensing models for our product portfolio, enabling our partners to expand their markets with trusted and approved pharmaceutical solutions.

parma-industry
close-up-blurry-scientist-holding-petri-dish

Our Vision

Our vision is to become a globally recognised, research-driven pharmaceutical leader and a trusted partner in Contract Development and Manufacturing (CDMO) and CMO services. We aim to deliver a comprehensive and differentiated portfolio of innovative, high-quality sterile injectable products, including advanced formats such as pre-filled syringes and lyophilised vials and nano-milled drugs. By setting new benchmarks in pharmaceutical development, state-of-the-art manufacturing, and regulatory excellence, we aspire to advance global healthcare. Through scientific integrity, operational efficiency, and strategic collaboration, we are committed to improving patient outcomes and shaping the future of sterile pharmaceutical solutions worldwide.

Our Mission

At Abryl Laboratories, our mission is to be a trusted global partner in pharmaceutical manufacturing by delivering high-quality, cost-effective sterile injectable products that fully comply with stringent international regulatory standards, including those of the US FDA and EU GMP. We are committed to enabling the successful commercialization of pharmaceutical products through advanced manufacturing technologies, robust quality systems, and flexible, customer-centric solutions. Through strategic collaborations and a focus on operational excellence, we strive to meet the evolving needs of both regulated and international markets while creating lasting value for our customers, partners, stakeholders, and employees.
top-view-various-syringes